Hill-Rom has introduced the VisiVest System, a connected therapeutic solution for patients in need of airway clearance therapy. The system is the world’s first solution combining high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity powered by Qualcomm Life Inc.
The VisiVest System provides therapy adherence data that may help inform decisions caregivers make for their patients, resulting in reduced risk of respiratory infections, hospitalizations, and medical costs, Hill-Rom said.
Patients’ usage data from the VisiVest System is remotely and securely transmitted to the VisiView Health Portal via Qualcomm Life’s 2net Hub. The VisiView Health Portal displays data trends in an easy-to-use dashboard format. This connectivity fosters a closer partnership between patients and healthcare teams, so treatment decisions by caregivers can be more tailored and responsive, which may result in better therapy adherence, the company said in a press release.
“In healthcare, the ability to make decisions based on accurate, timely information is essential,” said Alton Shader, president, Front Line Care at Hill-Rom. “The VisiVest System and Qualcomm Life’s 2net connectivity solution bring care teams and patients closer, helping to better manage patients’ illness and improve their quality of life.”
In a pilot study conducted over the past few months, 160 patients from seven cystic fibrosis clinics have adopted The VisiVest System. Hill-Rom reported enthusiasm and excitement for the technology from patients and care teams.
“What I like most about the VisiVest System is being able to see my patients’ session data and trends,” said Tom Newton, pulmonary therapist, Miller Children’s Hospital, Long Beach, CA. “Now I’m not just telling my patients the more adherent they are to their therapy, the higher their pulmonary function numbers are likely to be. We can actually look at their adherence score together and have a more comprehensive conversation about their numbers.”